The AI newswire
Partnership will leverage Iktos’s AI-enabled drug discovery platform and Cube Biotech’s advanced protein technologies to develop novel agonists of the Amylin Receptor PARIS and MONHEIM, Germany — January 10, 2025…
The analysis provides detailed insights to optimize clinical trial strategy, accelerate development, and de-risk decision-making. SAN FRANCISCO, Calif. — January 13, 2025 — A28 Therapeutics, Inc., a clinical-stage biopharmaceutical company…
Combined entity to be named Machinify, with revenue of more than $500 million Accelerates transformation of healthcare administration through addition of AI-native technology platform NEW YORK, N.Y., DALLAS, Tex. and…
LAS VEGAS, Nev. — January 10, 2025 — RingConn, a leading smart wearable brand, is proud to announce its participation in this year’s CES, showcasing two groundbreaking products on the…
Company reports 300% revenue growth in 2024 and advances partnerships with nation’s leading health systems LOUISVILLE, Ky. — January 10, 2025 — RAAPID, the industry-leading healthcare AI company, announced today…
FLORENCE, Italy and CAMBRIDGE, Mass. — January 10, 2025 — The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of…
HUNTINGTON, N.Y. — January 10, 2025 — Sen-Jam Pharmaceutical (“Sen-Jam”), a pioneer in innovative inflammatory care, today announced a planned new initiative for use of leading-edge AI tools to accelerate…
MINNEAPOLIS, Minn. — January 10, 2025 — Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced…
Partnership Will Harness NYSCF’s Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level NEW YORK, N.Y. — January 10, 2025 — The New…
IRVINE, Calif. — January 9, 2025 — GATC Health is redefining the landscape of Post-Traumatic Stress Disorder (PTSD) treatment and drug discovery through its proprietary Multiomics Advanced Technology™ (MAT) artificial…